Medifast Revenue Growth: 13.06%
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
None selected
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
MED Revenue Growth Rankings
| Overall | 61st percentile | 1709 of 4424 |
| Sector | 65th percentile | 296 of 868 in Services |
| Industry | 72nd percentile | 9 of 33 in Specialty Retail, Other |
MED Revenue Growth Range, Past 5 Years
| Minimum | -82.24% | Sep 1999 |
| Maximum | 341.49% | Jun 1995 |
| Average |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
You may also be interested in these MED related companies
MED News
Auriga reiterates a 'Buy' on Weight Watchers (WTW); Q4 Preview; Guidance May Act As Catalyst
Feb 10, 11:25AM Street Insider
Feb 10, 11:25AM Street Insider
Auriga Reiterates a 'Buy' on Medifast (MED); Management Change Shouldn't Alter 2012 Plans
Feb 03, 12:07PM Street Insider
Feb 03, 12:07PM Street Insider
Canaccord Genuity Maintains a 'Hold' on Medifast (MED); Management Change At The Top, Probably More To Come
Feb 03, 9:47AM Street Insider
Feb 03, 9:47AM Street Insider
Medifast Announces Executive Chairman of the Board Michael C. MacDonald to Become CEO
Feb 02, 4:06PM Benzinga
Feb 02, 4:06PM Benzinga
Standpoint Research Starts Medifast (MED) at Buy; This Consumer Staple Has Value
Jan 30, 9:50AM Street Insider
Jan 30, 9:50AM Street Insider
Medifast Kicks Off 2012 With Success Story Featured in People Magazine "Half Their Size" Issue
Jan 09, 4:09PM PR Newswire
Jan 09, 4:09PM PR Newswire
Canaccord Genuity Maintains a 'Hold' on Medifast (MED); Panned By Barron's To Begin The Diet Season
Jan 09, 8:59AM Street Insider
Jan 09, 8:59AM Street Insider
Poetic. RT @The_Real_Fly Breaking Your BAC http://stks.co/1nKs $BAC, $WTW, $NTRI, $MED, $DIET, $BC
about 38 days ago by wallstreetbean
about 38 days ago by wallstreetbean
Breaking Your BAC http://stks.co/1n9t $BAC, $WTW, $NTRI, $MED, $DIET, $BC
about 38 days ago by The_Real_Fly
about 38 days ago by The_Real_Fly
$MED Upside Blowoff - 15 Minute Down Reversal - Red bar after 4 green bars
about 40 days ago by TradeIdeasQuant
about 40 days ago by TradeIdeasQuant
$MED can't make a valuation argument... been "cheap" for too long. I'm more inclined to look for single digits (9.3) than a bounce.
about 82 days ago by tickertutor
about 82 days ago by tickertutor
A Change in Tides - Featured Research on Medifast, Inc. and Ultrapar Participacoes SA (ADR)
Nov 22, 9:00AM Marketwire
Nov 22, 9:00AM Marketwire
Canaccord Genuity Maintains a 'Buy' on Medifast (MED); Direct Selling Momentum Lost
Nov 04, 10:44AM Street Insider
Nov 04, 10:44AM Street Insider
Some new MFI stocks! First is Medifast $MED. Weight loss products. #1 on Forbes "Best Small Companies" list for 2010. Growth, low debt.
about 100 days ago by MagicDiligence
about 100 days ago by MagicDiligence
Medifast downgraded to Market Perform from Outperform at Northland Securities
Nov 04, 8:13AM FlyOnTheWall
Nov 04, 8:13AM FlyOnTheWall
NEW POST: "Going with the Flow" http://stks.co/YkP $APPL $MED $NFLX $QQQ $SPY
about 125 days ago by chessNwine
about 125 days ago by chessNwine
$MED http://stks.co/NHz From watch-list, hasn't triggered yet. I almost bought it today.
about 139 days ago by gtotoy
about 139 days ago by gtotoy
$MED Never got close to LIMIT order - will try to get filled again on Tuesday.
about 181 days ago by exkapie
about 181 days ago by exkapie
$MED successful test of low-entered BUY LONG order at Limit 16.88-if filled enter SellStop at 16.23 http://chart.ly/pkibogx
about 182 days ago by exkapie
about 182 days ago by exkapie
This week's Brewing Wealth http://stk.ly/qa0yT4 $EZPW $CEO $MED $RES $GRMN
about 187 days ago by wallstreetbean
about 187 days ago by wallstreetbean
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| MED | 17.33 | 0.34 | 2.00% | 267.75M |
| ALU | 2.19 | 0.25 | 12.89% | 4.96B |
| DIT | 65.30 | 0.03 | 0.04% | 40.48M |
| NOK | 4.96 | -0.11 | -2.17% | 18.58B |
| WFC | 30.26 | -0.32 | -1.05% | 159.58B |
| CVS | 43.18 | 0.18 | 0.42% | 56.20B |
| LIVE | 6.27 | 0.05 | 0.80% | 4.33M |
| VECO | 28.36 | 0.08 | 0.28% | 1.10B |
| LLY | 39.31 | -0.21 | -0.53% | 45.51B |
| APA | 105.13 | -1.55 | -1.45% | 40.36B |